Hosted on MSN23m
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock SoarsClinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback